[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-358836-105":59,"doc-detail-358836-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","single-cell-protein-activity-analysis-reveals-aberrant-myogenesis-and-igf2-pi3k-pathway-dependencies-in-myod1-mutant-rhabdomyosarcoma","Single-cell protein activity analysis reveals aberrant myogenesis and IGF2-PI3K pathway dependencies in MYOD1-mutant rhabdomyosarcoma","","Single-cell regulatory network analysis based on single-nucleus RNA sequencing was performed on six patient tumors with MYOD1-mutant spindle cell rhabdomyosarcoma to map disrupted myogenesis and actionable master regulator dependencies. Three coexisting tumor cell states were identified, including a MYOD1-enriched progenitor-like state, a proliferative transition state, and a partially differentiated state with reduced MYOD1 activity. Ligand-receptor and IGF2–IGF1R–PI3K signaling suggested a paracrine program driving transitions, and pathway inhibition improved ex vivo and patient-derived xenograft disease control, consistent with recurrent IGF2/PI3K/AKT alterations.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/single-cell-protein-activity-analysis-reveals-aberrant-myogenesis-and-igf2-pi3k-pathway-dependencies-in-myod1-mutant-rhabdomyosarcoma/358836/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/single-cell-protein-activity-analysis-reveals-aberrant-myogenesis-and-igf2-pi3k-pathway-dependencies-in-myod1-mutant-rhabdomyosarcoma/358836.png","ImageObject",300,407,{"name":92,"@type":93},"Levi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What makes MYOD1-mutant spindle cell rhabdomyosarcoma difficult to treat?","Question",{"text":112,"@type":113},"It is an ultrarare, treatment-resistant sarcoma with dismal outcomes and poor responsiveness to conventional chemotherapy, including limited durable responses and frequent relapse.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the study characterize tumor cell states in MYOD1L122R-mutant SRMS?",{"text":117,"@type":113},"The authors used regulatory network analysis of single-nucleus RNA sequencing from six patient tumors, identifying three coexisting cell states: MYOD1-enriched progenitor-like, proliferative transition, and partially differentiated with reduced MYOD1 activity.",{"name":119,"@type":110,"acceptedAnswer":120},"What signaling axis was implicated as actionable in the study?",{"text":121,"@type":113},"Ligand-receptor analysis highlighted paracrine IGF2–IGF1 receptor (IGF1R)–PI3K signaling from progenitor to transition/differentiated states, and its inhibition showed therapeutic potential in ex vivo drug screens and improved xenograft disease control.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},358836,1791001040,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","CANCER  \nSingle-cell protein activity analysis reveals aberrant myogenesis and IGF2-PI3K pathway dependencies in MYOD1-mutant rhabdomyosarcoma  \nJosephine K. Dermawan1, Fabio Vanoli2, Henry de Traux deWardin3, Jonathan N. Levi4, Glorymar Ibanez Sanchez5, Armaan Siddiquee5, Samantha Brosius5, Daoqi You5, Franck Tirode6, Patricia Sung2, Marie Karanian6, Daniel Pissaloux6, Leonard H. Wexler5, Andrew Kung5,  \nAlice Soragni4, Filemon S. Dela Cruz5, Jovana Pavisic5*, Cristina R. Antonescu2*  \nMyogenic differentiation 1 (MYOD1)L122R-mutant spindle cell rhabdomyosarcoma (SRMS) is an ultrarare, treatmentresistant sarcoma with dismal outcomes. We performed regulatory network analysis of single-nucleus RNA sequencing (snRNA-seq) from six patient tumors, revealing disrupted myogenesis and actionable master regulator (MR) dependencies across three coexisting tumor cell states, also conserved in patient-derived xenografts: (i) a MYOD1-enriched progenitor-like state, (ii) a proliferative transition state, and (iii) a partially differentiated state with reduced MYOD1 activity. Ligand-receptor analysis uncovered paracrine insulin-like growth factor 2 (IGF2) -IGF1 receptor (IGF1R)–phosphatidylinositol 3-kinase (PI3K) signaling from progenitor to transition/differentiated states, whose inhibition demonstrated therapeutic potential in ex vivo drug screens, and significantly improved disease control in a patient-derived xenograft model. Oncogenic MRs were recapitulated in 24 bulk RNA profiles, while 20 DNA profiles revealed recurrent IGF2/PI3K/AKT alterations, reinforcing shared transcriptional vulnerabilities. These findings characterize aberrant, mutant MYOD1–driven myogenesis sustained by IGF2 and nominate IGF1R-PI3K/AKT/mammalian target of rapamycin inhibitors for therapeutic translation in MYOD1L122R-mutant SRMS, underscoring the utility of single-cell regulatory network analysis for uncovering actionable dependencies in rare, transcriptionally complex cancers.  \ncopyright © 2026 the Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. no claim to original U.S.  \nGovernment Works. Distributed under a creative commons Attribution noncommercial license 4.0 (cc BY-nc) .  \nINTRODUCTION  \nMYOD1-mutant spindle cell/sclerosing rhabdomyosarcoma (SRMS) is an ultrarare and clinically aggressive soft tissue sarcoma that primarily affects children and young adults, with dismal outcomes ( 1–4). It is defined by a recurrent Leu122Arg (L122R) hotspot mutation in the myogenic differentiation 1 (MYOD1) gene that disrupts the normal function of this key transcription factor in skeletal muscle differentiation (5, 6). The disease exhibits poor responsiveness to conventional chemotherapy, with limited durable responses, high rates of relapse, and less than 20% 5-year survival (7, 8). While the defining mutation is well characterized, the regulatory programs that sustain tumor progression, intratumor heterogeneity, and therapy resistance remain poorly understood. Long-term survival is rare, and effective targeted therapies are lacking—underscoring the need for previously unexplored, mechanistically informed treatment strategies.  \nPediatric cancers typically exhibit a low mutational burden yet show substantial transcriptional and cellular heterogeneity that critically influences tumor behavior (9, 10) . In MYOD1L122R-mutant SRMS, 30 to 40% of tumors harbor recurrent, potentially actionable comutations, frequently involving the phosphatidylinositol 3-kinase  \n1Department of Pathology and laboratory Medicine, cleveland clinic, cleveland, Oh, USA. 2Department of Pathology and laboratory Medicine, Memorial Sloan Kettering cancer center, new York, nY, USA. 3Department of Pediatrics, Brussels University hospital, Academic children’s hospital Queen Fabiola, Université librede Bruxelles, Brussels, Belgium. 4Department of Orthopaedic Surgery, David Geffen School of Medicine, University of california, los Angeles, cA, USA. 5","cbCaikPZdLDZ49ns","https://ap.wps.com/l/cbCaikPZdLDZ49ns","pdf",5759603,23,"English","# Introduction\n## Disease background: MYOD1-mutant SRMS\n## Rationale and knowledge gap\n## Single-cell evidence in related RMS subtypes\n## Study approach: single-nucleus RNA sequencing\n## Complementary bulk profiling and validation","[{\"question\":\"What makes MYOD1-mutant spindle cell rhabdomyosarcoma difficult to treat?\",\"answer\":\"It is an ultrarare, treatment-resistant sarcoma with dismal outcomes and poor responsiveness to conventional chemotherapy, including limited durable responses and frequent relapse.\"},{\"question\":\"How did the study characterize tumor cell states in MYOD1L122R-mutant SRMS?\",\"answer\":\"The authors used regulatory network analysis of single-nucleus RNA sequencing from six patient tumors, identifying three coexisting cell states: MYOD1-enriched progenitor-like, proliferative transition, and partially differentiated with reduced MYOD1 activity.\"},{\"question\":\"What signaling axis was implicated as actionable in the study?\",\"answer\":\"Ligand-receptor analysis highlighted paracrine IGF2–IGF1 receptor (IGF1R)–PI3K signaling from progenitor to transition/differentiated states, and its inhibition showed therapeutic potential in ex vivo drug screens and improved xenograft disease control.\"}]","Single-cell protein activity analysis reveals aberrant myogenesis and IGF2-PI3K pathway dependencies in MYOD1-mutant rhabdomyosarcoma | PDF",1790135435,58,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9c8d1325e031981220d55dcdb93bbfd5.webp",983,1250,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ead389b00cd1b2db52c4e28b127e9a03.webp",982,1249,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/25c6ca66badf36942e13d75f9adab13b.webp",981,1248,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/11ce2f450adc0d81fe1ba2c8eb428ee3.webp",980,1247]